Skip to content

Stock-Based Comp at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$22.38M+70.4%
IQVIA logo
IQVIAIQV
$65M-9.7%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$4.92M-70.9%
Septerna, Inc. logo
Septerna, Inc.SEPN
$6.02M+306%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$10.2M+15.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$3.68M-76.6%

Other financials

Income statement

See full
Revenue$636.5M-2.3%
Gross profit$123.6M+6.1%
Operating income-$3.4M+99.3%
Net income-$23.6M+95.8%
EPS (diluted)-$0.25+96.0%

Balance sheet

See full
Cash & equivalents$147.5M+45.2%
Total debt$1.1B-13.1%
Total equity$525.9M-38.8%
Total assets$2.7B-14.0%

Cash flow

See full
Operating cash flow-$17.0M+86.3%
CapEx$8.0M+176%
Free cash flow-$25.0M+80.3%

Valuation

See full
Market cap$1.56B+29.3%
Enterprise value$2.53B-0.8%
P/S0.6×+0.1×

Profitability

See full
Gross margin18.9%-1.3pp
Operating margin-13.1%-4.1pp
Net margin-16.5%-5.0pp
FCF margin5.8%+1.7pp

Returns & leverage

See full
Return on equity-64.5%0.0pp
Debt / equity2.1×+0.6×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fortrea Holdings Inc.'s stock-based comp?
Fortrea Holdings Inc. (FTRE) reported stock-based comp of $11.4M in Q1 2026.
How has Fortrea Holdings Inc.'s stock-based comp changed year-over-year?
Fortrea Holdings Inc.'s stock-based comp decreased by 21.9% year-over-year, from $14.6M to $11.4M.
What is the long-term trend for Fortrea Holdings Inc.'s stock-based comp?
Over 3 years (2021 to 2025), Fortrea Holdings Inc.'s stock-based comp has grown at a 39.3% compound annual growth rate (CAGR), from $27.5M to $74.4M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.